Discrepancies Between the Tennessee Nomogram and Oncotype DX: Implications for the Korean Breast Cancer Population—The BRAIN Study
The Tennessee nomogram may be a useful surrogate when ODX testing is unavailable, but caution is warranted in patients with aggressive tumor biology. In such cases, ODX testing should be prioritized to guide adjuvant therapy decisions.
Authors
- Seho Park (ORCID: https://orcid.org/0000-0001-8089-2755)
- Joo Heung Kim (ORCID: https://orcid.org/0000-0002-0417-8434)
- So Hyeon Gwon
- Ilkyun Lee (ORCID: https://orcid.org/0000-0002-1546-5543)
- Suk Jun Lee (ORCID: https://orcid.org/0000-0003-3839-5071)
- Nak‐Hoon Son (ORCID: https://orcid.org/0000-0002-6192-8852)
- Jee Hyun Ahn (ORCID: https://orcid.org/0000-0003-4176-3277)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Catholic Kwandong University International St. Mary's Hospital (KR)
- Keimyung University (KR)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-21
- DOI
- https://doi.org/10.3390/cancers17183083
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- National Research Foundation
- Yonsei University
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Yonsei University College of Medicine